Transmural Systems

Transmural has successfully leveraged over $10 million in SBIR funding to advance development of new innovative medical devices that address unmet…

AstraZeneca

EGC supported AstraZeneca in securing over $8 million in NIH funding to advance its first-in-class therapeutic candidate into a Phase 2 clinical…

AgroSpheres

AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor…

Winsantor

Winsantor has secured over $14.3 million in non-dilutive NIH funding since 2014, enabling breakthroughs in neuropathy treatment and advancing to…

Kepley Biosystems

Kepley Biosystems Thrives with EGC’s Expert Accounting, Advancing Sustainable Technologies Since 2015.

InnAVasc

InnAVasc Medical acquired by W. L. Gore & Associates following $2M in NIH funding.

Lightengale

Lightengale's novel intravenous tubing system recognized by FDA, NIH, and NSF.

Bezwada Biomedical

Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.

Scioto Biosciences

Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.

Dignify Therapeutics

Dignify Therapeutics has secured >$20M in funding to assist in the development of their therapeutics for people with spinal cord injuries.

Laser Thermal

Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).

Ascent Integrated Tech

Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.

Accelerating development of innovative technologies

EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.

Book a Discovery Call